Performance
5 Days
0 0%
1 Month
0 0%
3 Months
1.50%
6 Months
-20.17%
1 Year
-20.17%
2 Year
38.29%
Key data
Stock price
$1.32
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.45 - $4.76
52 WEEK CHANGE
-$20.17
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Ron Babecoff
Region: US
Website: http://www.biondvax.com
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry:
Sector:
Region: US
Website: http://www.biondvax.com
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry:
Sector:
biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax’s technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.
Recent news